Abstract
Because standard techniques used to detect mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene do not detect single or multiple exonic rearrangements, the importance of such rearrangements may be underestimated. Using an in-house developed, single-tube, semi-quantitative fluorescent PCR (SQF PCR) assay, we analyzed 36 DNA samples submitted for extensive CFTR sequencing and identified ten samples with rearrangements. Of 36 patients with classic CF, 10 (28%) harbored various deletions in the CFTR gene, accounting for 14% of CF chromosomes. A deletion encompassing the CFTR promoter and exons 1 and 2 was detected in a sample from one proband, and in the maternal DNA as well. In another family, a deletion of the promoter and exon 1 was detected in three siblings. In both of these cases, the families were African American and the 3120+1G>A splice site mutation was also identified. These promoter deletions have not been previously described. In a third case, a deletion of exons 17a, 17b, and 18 was identified in a Caucasian female and the same mutation was detected in the paternal DNA. In the other seven cases, we identified the following deletions: exons 2 and 3 (n=2); exons 4, 5, and 6a; exons 17a and 17b; exons 22 and 23; and exons 22, 23, and 24 (n=2). In our series, the frequency of CFTR rearrangements in classic CF patients, when only one mutation was identified by extensive DNA sequencing, was >60% (10/16). Screening for exon deletions and duplications in the CFTR gene would be beneficial in classic CF cases, especially when only one mutation is identified by standard methodologies.
Similar content being viewed by others
References
Audrezet MP, Chen JM, Raguenes O, Chuzhanova N, Giteau K, Le Marechal C, Quere I, Cooper DN, Ferec C (2004) Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat 23:343–357
Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, Puisieux A, Frebourg T (2002) MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 62:848–853
Costes B, Girodon E, Vidaud D, Flori E, Ardalan A, Conteville P, Fanen P, Niel F, Vidaud M, Goossens M (2000) Prenatal detection by real-time quantitative PCR and characterization of a new CFTR deletion, 3600+15 kbdel5.3 kb (or CFTR dele19). Clin Chem 46:1417–1420
Cutting GR (2002) Cystic fibrosis. In: DL R, JM C, RE P, BR K (eds) Principles and practice of medical genetics, vol 2, 4 edn. Chrchill livingstone, London, pp 2685–2717
Dörk T, Macek M Jr, Mekus F, Tummler B, Tzountzouris J, Casals T, Krebsova A, Koudova M, Sakmaryova I, Macek M Sr, Vavrova V, Zemkova D, Ginter E, Petrova NV, Ivaschenko T, Baranov V, Witt M, Pogorzelski A, Bal J, Zekanowsky C, Wagner K, Stuhrmann M, Bauer I, Seydewitz HH, Neumann T, Jakubiczka S (2000) Characterization of a novel 21-kb deletion, CFTR dele2,3 (21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet 106:259–268
Ferec C, Audrezet MP, Chen JM, Raguenes O, Macek M, Bombieri C, Pignatti PF, Casals T, Cutting G, Williamson R, Barton D, McDevitt T, Fattoum S (2004) Abs. # 2547. Genomic rearrangments in the CFTR gene: results of a worldwide survey; analysis of mutational mechanisms. Abs. Ann Mtg ASHG, Toronto, Canada, p 459
Feuillet-Fieux MN, Ferrec M, Gigarel N, Thuillier L, Sermet I, Steffann J, Lenoir G, Bonnefont JP (2004) Novel CFTR mutations in black cystic fibrosis patients. Clin Genet 65:284–287
Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ (2001) Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 3:149–154
Lerer I, Laufer-Cahana A, Rivlin JR, Augarten A, Abeliovich D (1999) A large deletion mutation in the CFTR gene (3120+1 kbdel8.6 kb): a founder mutation in the Palestinian Arabs. Mutation in brief no. 231. Online. Hum Mutat 13:337
Liu X, Li X, Li M, Acimovic YJ, Li Z, Scherer SW, Estivill X, Tsui LC (2004) Characterization of the segmental duplication LCR7-20 in the human genome. Genomics 83:262–269
Mickle JE, Macek M Jr, Fulmer-Smentek SB, Egan MM, Schwiebert E, Guggino W, Moss R, Cutting GR (1998) A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum Mol Genet 7:729–735
Morral N, Nunes V, Casals T, Cobos N, Asensio O, Dapena J, Estivill X (1993) Uniparental inheritance of microsatellite alleles of the cystic fibrosis gene (CFTR): identification of a 50 kilobase deletion. Hum Mol Genet 2:677–681
Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731–740
Niel F, Martin J, Dastot-Le Moal F, Costes B, Boissier B, Delattre V, Goossens M, Girodon E (2004) Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis. J Med Genet 41:e118
Shrimpton AE, Borowitz D, Swender P (1997) Cystic fibrosis mutation frequencies in upstate New York. Hum Mutat 10:436–442
Strom CM, Huang D, Buller A, Redman J, Crossley B, Anderson B, Entwistle T, Sun W (2002) Cystic fibrosis screening using the College panel: platform comparison and lessons learned from the first 20,000 samples. Genet Med 4:289–296
Strom CM, Huang D, Chen C, Buller A, Peng M, Quan F, Redman J, Sun W (2003) Extensive sequencing of the cystic fibrosis transmembrane regulator gene: assay validation and unexpected benefits of developing a comprehensive test. Genet Med 5:9–14
Acknowledgments
We would like to thank Greg Putignani, Nadia Dekov and Jeremy Teigeiser for DNA sequencing and analysis of the CF cases, Christina Chen-Tubman for technical assistance, and Jeff Radcliff for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00439-006-0145-x
Rights and permissions
About this article
Cite this article
Hantash, F.M., Redman, J.B., Starn, K. et al. Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening. Hum Genet 119, 126–136 (2006). https://doi.org/10.1007/s00439-005-0082-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-005-0082-0